Azilect 1 mg

AZILECT 1 MG tablets contain rasagiline mesylate, a medication used to manage symptoms of Parkinson's disease. This oral tablet is manufactured by Teva Canada Limited and comes in a pack of 30.

AZILECT 1 MG tablets are primarily used to help manage the symptoms of Parkinson's disease. Rasagiline mesylate, the active ingredient, is often prescribed to improve motor function and reduce tremors. This medication is typically used as part of a broader treatment plan for Parkinson's disease, which may include other medications and therapies. What is AZILECT used for? It is commonly used to alleviate the symptoms associated with Parkinson's disease, such as stiffness, tremors, and difficulty moving.

Common effects of AZILECT 1 MG tablets may include dizziness, nausea, and headache. Some users may also experience insomnia or joint pain. These effects can vary from person to person, and not everyone will experience them. If any of these effects are severe or persistent, it is important to consult a healthcare professional.

AZILECT 1 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be taken with certain other drugs, particularly those that affect the central nervous system. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

AZILECT 1 MG tablets may interact with other medications, including those that affect the central nervous system. It is important to avoid taking this medication with MAO inhibitors, as this can lead to serious side effects. Additionally, alcohol and certain antidepressants may interact with rasagiline mesylate, so it is crucial to discuss all current medications with a healthcare professional before starting AZILECT.